Top

Published in:

01-08-2006

Postsurgical Infections are Reduced with Specialized Nutrition Support

Authors: Dan L. Waitzberg, MD, Hideaki Saito, MD, Lindsay D. Plank, PhD, Glyn G. Jamieson, MD, Palepu Jagannath, MD, Tsann-Long Hwang, MD, Juan M. Mijares, MD, David Bihari, MD

Published in: World Journal of Surgery | Issue 8/2006

Abstract

Objective

The objective was to examine the relationship between pre-, peri-, and postoperative specialized nutritional support with immune-modulating nutrients and postoperative morbidity in patients undergoing elective surgery.

Methods

Studies were identified by searching MEDLINE, review article bibliographies, and abstracts and proceedings of scientific meetings. All randomized clinical trials in which patients were supplemented by the IMPACT formula before and/or after elective surgery and the clinical outcomes reported were included in the meta-analysis. Seventeen studies (n = 2,305), 14 published (n = 2,102), and 3 unpublished (n = 203), fulfilled the inclusion criteria. Ten studies (n = 1,392) examined the efficacy of pre- or perioperative IMPACT supplementation in patients undergoing elective surgery, whereas 7 (n = 913) assessed postoperative efficacy. Fourteen of the studies (n = 2,083) involved gastrointestinal (GI) surgical patients. Postoperative complications, mortality, and length of stay in hospital (LOS) were major outcomes of interest.

Results

IMPACT supplementation, in general, was associated with significant (39%–61%) reductions in postoperative infectious complications and a significant decrease in LOS in hospital by an average of 2 days. The greatest improvement in postoperative outcomes was observed in patients receiving specialized nutrition support as part of their preoperative treatment. In GI surgical patients, anastomotic leaks were 46% less prevalent when IMPACT supplementation was part of the preoperative treatment.

Conclusion

This study identifies a dosage (0.5–1 l/day) and duration (supplementation for 5–7 days before surgery) of IMPACT that contributes to improved outcomes of morbidity in elective surgery patients, particularly those undergoing GI surgical procedures. The cost effectiveness of such practice is supported by recent health economic analysis. Findings suggest preoperative IMPACT use for the prophylaxis of postoperative complications in elective surgical patients.

Tepaske R, te Velthuis H, Oudemans-van Straaten HM, et al. Effect of preoperative oral immune-enhancing nutritional supplement on patients at high risk of infection after cardiac surgery: a randomised placebo-controlled trial. Lancet 2001;358:696–701PubMedCrossRef

Heys SD, Walker LG, Smith I, et al. Enteral nutrition supplementation with key nutrients in patients with critical illness and cancer. Ann Surg 1999;229:476–477CrossRef

Beale RJ, Bryg DJ, Bihari DJ. Immunonutrition in the critically ill: a systematic review of clinical outcome. Crit Care Med 1999;27:2799–2805PubMedCrossRef

Heyland DK, Novak F, Drover JW, et al. Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA 2001;286:944–953PubMedCrossRef

Montejo JC, Zarazaga A, Lopez-Martinez J, et al. Immunonutrition in the intensive care unit. A systematic review and consensus statement. Clin Nutr 2003;22:221–233PubMedCrossRef

Wyncoll D, Beale R. Immunologically enhanced enteral nutrition: current status. Curr Opin Crit Care 2001;7:128–132PubMedCrossRef

Daly JM, Lieberman MD, Goldfine J, et al. Enteral nutrition with supplemental arginine, RNA, and omega-3 fatty acids in patients after operation: immunologic, metabolic, and clinical outcome. Surgery 1992;112:327–338

Gianotti L, Braga M, Frei A, et al. Health care resources consumed to treat postoperative infections: cost savings by perioperative immunonutrition. Shock 2000;14:325–330PubMedCrossRef

Kemen M, Senkal M, Homann HH, et al. Early postoperative enteral nutrition with arginine, omega-3 fatty acids, and ribonucleic acid-supplemented diet versus placebo in cancer patients: an immunologic evaluation of IMPACT^®. Crit Care Med 1995;23:652–659PubMedCrossRef

10.

Senkal M, Kemen M, Homann HH, et al. Modulation of postoperative immune response by enteral nutrition with a diet enriched with arginine, RNA, and omega-3 fatty acids in patients with upper gastrointestinal cancer. Eur J Surg 1995;161:115–122PubMed

11.

Braga M, Gianotti L, Gestari A, et al. Gut function, immune and inflammatory responses in patients fed perioperatively with supplemented formulas. Arch Surg 1996;131:1257–1265PubMed

12.

Wachtler P, Hilger RA, König W, et al. Influence of a pre-operative enteral supplement on functional activities of peripheral leukocytes from patients with major surgery. Clin Nutr 1995;14:275–282PubMedCrossRef

13.

Kulkarni AD, Rudolph FB, Van Buren CT. The role of dietary sources of nucleotides in immune function: a review. J Nutr 1994;124:1442S–1446SPubMed

14.

Kirk SJ, Hurson M, Regan MC, et al. Arginine stimulates wound healing and immune function in elderly human beings. Surgery 1993;114:155–160PubMed

15.

Sato H, Zhao ZQ, McGee DS, et al. Supplemental L-arginine during cardioplegic arrest and reperfusion avoids regional postischemic injury. J Thorac Cardiovasc Surg 1995;110:302–314PubMedCrossRef

16.

Jones SM, Thurman RG. L-arginine minimizes reperfusion injury in a low-flow, reflow model of liver perfusion. Hepatology 1996;24:163–168PubMed

17.

Nonami Y. The role of nitric oxide in cardiac surgery. Surg Today 1997;27:583–592PubMedCrossRef

18.

O’Leary MJ, Coakley JH. Nutrition and immunonutrition. Br J Anaesth 1996;77:118–127PubMed

19.

Meydani SN, Dinarello CA. Influence of dietary fatty acids on cytokine production and its clinical implications. Nutr Clin Pract 1993;8:65–72PubMed

20.

Calder PC. Immunoregulatory and anti-inflammatory effects of n-3-polyunsaturated fatty acids. Braz J Med Biol Res 1998;31:467–490PubMedCrossRef

21.

Luiking YC, Poeze M, Dehong CH, et al. Sepsis: an arginine deficiency state? Crit Care Med 2004;32(10):2135–2145PubMedCrossRef

22.

Burdett S, Stewart LA, Tierny JF. Publication bias and meta-analysis. Int J Technol Assess Health Care 2003;19:129–134PubMedCrossRef

23.

Heyland DK, MacDonald S, Keefe L, et al. Total parenteral nutrition in the critically ill patient: a meta-analysis. JAMA 1998;280:2013–2019PubMedCrossRef

24.

Jadad A. Random controlled trials. London: BMJ, 1998

25.

Rothman KJ, Boice JD. Epidemiological analysis with a programmable calculator. Washington, DC, National Institutes of Health, 1979

26.

Fleiss JL, Gross AJ. Meta-analysis in epidemiology, with special reference to studies of the association between exposure to environmental tobacco smoke and lung cancer. J Clin Epidemiol 1991;44:127–139PubMedCrossRef

27.

Hedges LV. Estimation of effect size from a series of independent experiments. Psychol Bull 1982;92:490–499CrossRef

28.

Braga M, Gianotti L, Vignali A, et al. Preoperative oral arginine and –3 fatty acid supplementation improves the immunometabolic host response and outcome after colorectal resection for cancer. Surgery 2002;132:805–814PubMedCrossRef

29.

Gianotti L, Braga M, Nespoli L, et al. A randomized controlled trial of preoperative oral supplementation with a specialized diet in patients with gastrointestinal cancer. Gastroenterology 2002;122:1783–1770CrossRef

30.

Braga M, Gianotti L, Nespoli L, et al. Nutritional approach in malnourished surgical patients: a prospective randomized study. Arch Surg 2002;137:174–180PubMedCrossRef

31.

Daly JM, Weintraub FN, Shou J, et al. Enteral nutrition during multimodality therapy in upper gastrointestinal cancer patients. Ann Surg 1995;221:327–338PubMed

32.

Schilling J, Vranjes N, Fierz W, et al. Clinical outcome and immunology of postoperative arginine, omega-3 fatty acids, and nucleotide-enriched enteral feeding: a randomized prospective comparison with standard enteral and low calorie/low fat i.v. solution. Nutrition 1996;12:423–429PubMedCrossRef

33.

Senkal M, Mumme A, Eickhoff U, et al. Early postoperative enteral immunonutrition: clinical outcome and cost-comparison analysis in surgical patients. Crit Care Med 1997;25:1489–1496PubMedCrossRef

34.

Heslin MJ, Latkany L, Leung D, et al. A prospective, randomized trial of early enteral feeding after resection of upper gastrointestinal malignancy. Ann Surg 1997;226:567–577PubMedCrossRef

35.

Gianotti L, Braga M, Vignali A, et al. Effect of route of delivery and formulation of postoperative nutritional support in patients undergoing major operations for malignant neoplasms. Arch Surg 1997;132:1222–1230PubMed

36.

Jiang ZM. The role of immune enhanced enteral nutrition on plasma amino acid, gut permeability and clinical outcome in post-surgery patients. Acta Chin Acad Med Sci 2001;23:515–518

37.

Senkal M, Zumtobel V, Bauer KH, et al. Outcome and cost-effectiveness of perioperative enteral immunonutrition in patients undergoing elective upper gastrointestinal tract surgery: a prospective randomized study. Arch Surg 1999;134:1309–1316PubMedCrossRef

38.

Snyderman CH, Kachman K, Molseed L, et al. Reduced postoperative infections with an immune-enhancing nutritional supplement. Laryngoscope 1999;109:915–921PubMedCrossRef

39.

Braga M, Gianotti L, Radaelli G, et al. Perioperative immunonutrition in patients undergoing cancer surgery: results of a randomized double-blind phase 3 trial. Arch Surg 1999;134:428–433PubMedCrossRef

40.

Braga M, Bianotti L. Preoperative immunonutrition: cost-benefit analysis. J Parenter Enteral Nutr 2005;29(1):S57–S61

41.

Wheeler JM, Gilbert JM. Controlled intraoperative water testing of left-sided colorectal anastomoses: are ileostomies avoidable? Ann R Coll Surg Engl 1999;81:105–108PubMed

42.

Strickland A, Brogan A, Krauss J, et al. Is the use of specialized nutritional formulations a cost-effective strategy? A national database evaluation. J Parenter Enteral Nutr 2005;29(1):S81–S91CrossRef

43.

Vignali A, Gianotti L, Braga M, et al. Altered microperfusion at the rectal stump is predictive for rectal anastomotic leak. Dis Colon Rectum 2000;43:76–82PubMedCrossRef

Title: Postsurgical Infections are Reduced with Specialized Nutrition Support
Authors: Dan L. Waitzberg, MD
Hideaki Saito, MD
Lindsay D. Plank, PhD
Glyn G. Jamieson, MD
Palepu Jagannath, MD
Tsann-Long Hwang, MD
Juan M. Mijares, MD
David Bihari, MD
Publication date: 01-08-2006
Publisher: Springer-Verlag
Published in: World Journal of Surgery / Issue 8/2006
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI: https://doi.org/10.1007/s00268-005-0657-x

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Postsurgical Infections are Reduced with Specialized Nutrition Support

Abstract

Objective

Methods

Results

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Objective

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 8/2006

Biliary Cystadenoma and Other Complicated Cystic Lesions of The Liver: Diagnostic and Therapeutic Challenges

Pancreatic Serous Oligocystic Adenomas: Clinicopathologic Features and a Comparison with Serous Microcystic Adenomas and Mucinous Cystic Neoplasms

Specific Targeting of Pancreatic Islet Cells In Vivo by Insulin-Promoter-Driven Adenoviral Conjugated Reporter Genes

Minimally Invasive Esophagectomy for Cancer: Prospective Evaluation of Laparoscopic Gastric Mobilization

Cartographies of Disease. Maps, Mapping, and Medicine. Tom Koch, ESRI Press, Redlands, CA, 2005, 388 pp, $ 28.32

Tolstoy’s Report of Five Cases of Chest Trauma: Its Relevance to Contemporary Military Surgical Experience